Treatment Approach for Hypercholesterolemia with Elevated LDL
Risk Assessment and Treatment Goals
- The American College of Cardiology recommends that patients with elevated LDL-C, such as a patient with an LDL-C of 167 mg/dL, should have treatment goals based on their overall cardiovascular risk profile, with high-risk patients aiming for an LDL-C goal <100 mg/dL 2, 3
- For very high-risk patients, the American Heart Association suggests an LDL-C goal <70 mg/dL as a therapeutic option 2, 4
- The National Lipid Association recommends that moderately high-risk patients, such as those with ≥2 risk factors and 10-year risk 10-20%, should aim for an LDL-C goal <130 mg/dL 2, 3
- Non-HDL cholesterol should be <130 mg/dL as a secondary treatment goal, according to the American College of Cardiology 5
First-Line Pharmacological Approach
- The American College of Cardiology recommends initiating maximally tolerated high-potency statin therapy, such as atorvastatin, rosuvastatin, or pitavastatin, to achieve LDL-C reduction goals 1
- Adding ezetimibe 10 mg daily to statin therapy can enhance LDL-C reduction, as suggested by the National Lipid Association 1
- The American Heart Association recommends that when LDL-lowering drug therapy is employed, intensity should be sufficient to achieve at least a 30-40% reduction in LDL-C levels 2, 3
Additional Therapeutic Options
- If LDL-C goals are not achieved with statin plus ezetimibe, the American College of Cardiology recommends considering PCSK9-targeted therapy, such as monoclonal antibodies or inclisiran, as an additional therapeutic option 1
- The National Lipid Association suggests considering plant sterols/stanols or bile acid sequestrants, such as colesevelam, as adjunctive therapies 1
Therapeutic Lifestyle Changes
- The American Heart Association recommends that all patients should receive advice on cardiovascular risk factors and lifestyle modifications, including a fat-modified, heart-healthy diet, regular physical exercise, smoking cessation, weight management, and moderation in alcohol intake 1, 2
- Lifestyle modifications should be implemented regardless of LDL-C level in patients with cardiovascular risk factors, as suggested by the American College of Cardiology 2, 3